Federal Circuit Finds Prosecution History Disclaimer In Enablement Arguments Mondaq News Alerts (registration) The specification describes Biogen's product Rituxan® (rituximab) as a preferred embodiment. Rituximab binds to a large loop of the CD20 protein that is exposed on the cell surface. This loop constitutes the particular "epitope" recognized by the ... |
